/Content/Upload/Product/Human_ELISA_kits_Diagnocine_1200_1200(5).jpg

Human Brain derived neurotrophic factor,BDNF ELISA Kit

Product#: CS-CSB-E04501h-IS
$580.00
Availability:
Ships in 24 hours

The Ultimate 1-Stop ELISA Marketplace:

60,000+ ELISA kits Available to Serve Scientists from All Fields of Life Science

Always Powered by Diagnocine for Precision Research.

 
Made In-USA · ISO 13485 Certified 

Most comprehensive buffers, reagents and detection agents are provided with each kit to optimize data output.  
All-inclusive format covers everything from sample preparation to signal detection.  Every step can be customized and optimized for your precision research.
DiagnoCine Precision buffers and reagents are Made in USA ISO 13485 Certified

One Stop Purchasing but Zero Compromise on Accuracy

Why waste time searching for your ELISA kit when you can get everything in one place? Diagnocine can provide you with all the ELISA needs you have (customized ELISAs also available) on the planet through a single, streamlined ordering process.  
* all types of species
* HRP and AP detection
* Low target signal enhancement
* Inquire about a trial version or a customized version

Low Signal Optimization Reagents

4 core reagents below are included with every order, plus 1 of the 2 detection-specific reagents (matched automatically to your kit type) — 5 components, every time.

DCP-PIC100X

Protease Inhibitor Cocktail (100X)

Included with every order
 DCP-SM1AbTBS1X

SigMax 1Ab-TBS

Included with every order
 DCP-UTBS1X

Universal Blocking Buffer

Included with every order
 DCP-SM2AbTBS1X

SigMax 2Ab-TBS

Included with every order

+ the 5th component, matched to your kit's detection method:

DCP-HRPTBS1X

HRPQuench-TBS

Exclusively for HRP-based kits
OR
DCP-ALPTBS1X

ALPQuench-TBS

Exclusively for ALP-based kits

If you have any questions or need additional information, please call us at 551-245-1033 or email us at support@diagnocine.com. Our team will be happy to assist you.

Key Value Highlights

Universal Compatibility

All buffers and detection reagents work seamlessly across target proteins, bridging the gap in assay consistency.

1-Stop Convenience

Consolidate your lab's purchasing. Source all ELISA needs and experience optimal buffers and reagents in a single shipment.

Enhanced Precision

Designed by scientists for scientists,  all components are engineered to deliver sharper results and an optical signal.

Human ELISA Kit · Cardiovascular

Human Brain derived neurotrophic factor,BDNF ELISA Kit

Sandwich quantitative immunoassay for Human Brain derived neurotrophic factor,BDNF in human serum, plasma, cell culture supernates, tissue homogenates.  available in multiple catalog sizes:

Trial 24T 96T

Note: Please send inquiries regarding Trial 24T orders to support@diagnocine.com.

Detection Range
15.6-1,000 pg/ml
Sensitivity
3.9 pg/ml
Assay Time
1-5 hours
Sample Volume
50-100 μL
Product specifications
Uniprot No.P23560
SpeciesHomo sapiens (Human)
Sample typesserum, plasma, cell culture supernates, tissue homogenates.
Detection range15.6 pg/ml-1000 pg/ml
Sensitivity3.9 pg/ml
Assay time1-5h
Sample loading volume50-100μL
Detection wavelength450 nm
Assay principleSandwich (Quantitative)
Data analysisStandard curve + Curve Expert software
Research areaCardiovascular
Storage condition2-8°C (see protocol for full details)
Shipping condition4 °C
Shelf life6 months
Human Brain derived neurotrophic factor,BDNF serum plasma cell culture supernates tissue homogenates. Cardiovascular Human ELISA
Lead Time

10 business days

Processing + 3-5 days shipping

Availability

In Stock : USA

Worldwide shipping available

Assay principle
Sample prep
Antibody capture
450 nm detection
Standard curve
Quantification

In this sandwich ELISA, Human Brain derived neurotrophic factor,BDNF in the sample is captured between a pre-coated capture antibody and a detection antibody. Signal intensity is proportional to analyte concentration. Quantification uses a standard curve fitted with Curve Expert software, covering 15.6 pg/ml-1000 pg/ml with a minimum detectable dose of 3.9 pg/ml.

For research use only (RUO). Not intended for diagnostic or therapeutic purposes. Validated in human serum, plasma, cell culture supernates, tissue homogenates. matrices only.
Description

This ELISA kit provides quantitative measurement of Brain-Derived Neurotrophic Factor (BDNF) in human samples, designed for cardiovascular research where BDNF serves as both a neurotrophic factor and an emerging cardiometabolic biomarker. Because circulating BDNF levels fluctuate significantly between platelet-bound stores and free plasma fractions, this kit is engineered to accommodate the concentration variability researchers encounter across serum, plasma, and tissue-derived samples.

Detection Range: The 62.5–4000 pg/ml range captures the broad spread between low plasma BDNF levels (often 100–500 pg/ml) and substantially higher serum concentrations (5,000–40,000 pg/ml) where platelet degranulation releases stored BDNF. Serum samples will typically require dilution, while plasma and conditioned media samples can often be run neat.

Alternative Names
Abrineurin ELISA Kit; ANON2 ELISA Kit; BDNF ELISA Kit; BDNF_HUMAN ELISA Kit; Brain Derived Neurotrophic Factor ELISA Kit; Brain-derived neurotrophic factor ELISA Kit; BULN2 ELISA Kit; MGC34632 ELISA Kit; Neurotrophin ELISA Kit
Function
Important signaling molecule that activates signaling cascades downstream of NTRK2. During development, promotes the survival and differentiation of selected neuronal populations of the peripheral and central nervous systems. Participates in axonal growth, pathfinding and in the modulation of dendritic growth and morphology. Major regulator of synaptic transmission and plasticity at adult synapses in many regions of the CNS. The versatility of BDNF is emphasized by its contribution to a range of adaptive neuronal responses including long-term potentiation (LTP), long-term depression (LTD), certain forms of short-term synaptic plasticity, as well as homeostatic regulation of intrinsic neuronal excitability.; Important signaling molecule that activates signaling cascades downstream of NTRK2. Activates signaling cascades via the heterodimeric receptor formed by NGFR and SORCS2. Signaling via NGFR and SORCS2 plays a role in synaptic plasticity and long-term depression (LTD). Binding to NGFR and SORCS2 promotes neuronal apoptosis. Promotes neuronal growth cone collapse.
Gene References into Functions
  1. Results show that Lnc RNA BDNF-AS inversely regulates the expression level of BDNF which modulates high-glucose induced apoptosis in human retinal pigment epithelial cells. PMID: 28657668
  2. This study shows the genetic correlates of early trauma in a group of schizophrenia patients (BDNF Met carriers). PMID: 28711474
  3. that the BDNF SNP rs1157659 interacted with mild traumatic brain injury to predict hippocampal volume PMID: 28755387
  4. polymorphisms in BDNF gene including rs925946, rs10501087, rs6265 and rs988712 can be considered as genetic determinants of obesity (systematic review and meta-analysis). PMID: 28818748
  5. This study show a linear relationship between the BDNF Val66Met genotypes and plasma BDNF levels in Caucasian depressed patients. PMID: 28848102
  6. the BDNF Val66Met polymorphism is associated with functional tuning of behaviorally-relevant frontolimbic circuitry, particularly involving the ventromedial prefrontal cortex, during higher-order learning. PMID: 28867340
  7. BDNF/TrkB axis plays a role in epithelial mesenchymal transition promoting the acquisition of (myo)fibroblast cell phenotype in idiopathic pulmonary fibrosis. PMID: 28938915
  8. Study shows that brain-derived neurotrophic factor concentrations in serum and peritoneal fluid were significantly higher in women with endometriosis with pain compared to women with endometriosis without pain. PMID: 28954602
  9. Met allele of the Val66Met polymorphism in brain derived neurotrophic factor is associated with lower BMI-SDS in children PMID: 28960774
  10. This study showed that in first-episode psychosis subjects, with global DNA hypo-methylation and reduced BDNF gene-expression. PMID: 29056292
  11. found evidence that supported the hypothesis that BDNF Val66Met polymorphism moderated the relationship between stress and depression. PMID: 29102837
  12. Meta-analysis/Review: patients with ischemic stroke at high risk of post stroke depression have lower BDNF levels at the early stage of stroke. PMID: 29128330
  13. found that though there was no significantly difference in peripheral BDNF levels between ADHD patients and control groups overall, BDNF levels were significantly higher in males with ADHD compared with controls. PMID: 29132072
  14. This study demonstrated that a significantly higher incidence of defective BDNF expression in granule layers of the cerebellar cortex. PMID: 29174061
  15. MicroRNA-103 suppresses glioma cell proliferation and invasion by targeting BDNF. PMID: 29257320
  16. There was a statistically significant change in BDNF levels post-chemotherapy in early-stage breast cancer patients, and plasma BDNF levels were associated with self-perceived concentration deficit in patients receiving chemotherapy. PMID: 29258453
  17. BDNF rs11030101 and BDNF rs61888800are associated with change of temperament scores in a clinical sample of subjects with major depression (MDD), who received selective serotonin reuptake inhibitor treatment. PMID: 29310728
  18. The functional Val66Met BDNF polymorphism is not associated with BDNF serum levels in acute episode of schizophrenia and depression. PMID: 29331787
  19. High expression levels of BDNF was observed in cervical cancer.BDNF role in epithelial-mesenchymal transition, migration and invasion of cervical cancer. PMID: 29345295
  20. Serum BDNF was significantly lower in patients with Parkinson's disease than in patients with essential tremor and controls. PMID: 29350074
  21. Our study provides evidence for the correlation between the BDNF variant rs6265 and emotional symptoms in the early phase after mild traumatic brain injury. PMID: 29357818
  22. Study suggested that BDNF 196 G>A polymorphism may be a genetic marker for predicting insulin resistance before initiating risperidone treatment in autism spectrum disorder patients. PMID: 29369497
  23. In a 12-year longitudinal population-based sample of older adults (n = 2,218), we used growth curve modeling to investigate whether the benefits of physical activity on cognitive preservation differed by BDNF genotype and sex across multiple cognitive domains including processing speed, attention, working memory, and episodic verbal memory. PMID: 29402782
  24. Coronary artery disease patients exhibited significantly lower plasma BDNF and higher vWF levels than those of control patients. PMID: 29409455
  25. No significant difference was found in the BDNF Val66Met polymorphism between patients with GAD and healthy controls, nor was this polymorphism significantly associated with antidepressant drug efficacy for GAD PMID: 29446659
  26. Review/Meta-analysis: suggests a lower risk of ischemic stroke for the GG genotype of BDNF rs6265. PMID: 29449128
  27. The results of this study suggest that the Val66Met polymorphism does not predict long-term, functional mobility following stroke. PMID: 29480080
  28. Low brain derived neurotrophic factor may contribute to the pathogenesis of schizophrenia, but maybe not to its cognitive impairments. PMID: 29482040
  29. Its single-nucleotide polymorphisms involves in dopaminergic metabolism and motor and cognitive function in older adults. PMID: 29525179
  30. Angiogenin contributes to angiogenesis induced by Brain-derived neurotrophic factor (BDNF). PMID: 29573867
  31. The sample consisted of 181 suicide cases (47 early suicide cases, 134 late suicide cases) and 162 controls. Patients with the BDNF Met allele had a 1.42-fold increased risk of suicide when compared with the Val allele carrier. When a suicide case is stratified by occurrence time, patients with the Met/Val or Met/Met genotype had a 2.48-fold increased risk of committing suicide early than those with the Val/Val genotype. PMID: 29734216
  32. Neurotrophic factors and hippocampal activity in PTSD PMID: 29799860
  33. combining cognitive and physical exercise had no additional or synergistic effect on peripheral BDNF levels compared with physical exercise alone PMID: 29842831
  34. while the BDNF Val66Met Megroup displayed significant SICI reduction in the bilateral M1 in response to motor training, short-interval intracortical inhibition (SICI) remained unchanged in the BDNF Val66Met group. PMID: 29856758
  35. serum BDNF levels and the BDNF Val66Met polymorphism in healthy young adults were associated with the sleep pattern on weekends but not with that on weekdays, suggesting that the systems involved in BDNF control may be linked to endogenous sleep characteristics rather than the socially constrained sleep schedule in healthy young adults. PMID: 29944703
  36. Findings demonstrated that polymorphism Val66Met is not associated with temporal lobe epilepsy caused by hippocampal sclerosis, epilepsy-related factors and psychiatric comorbidities in this selected group of patients. PMID: 30015148
  37. platelet BDNF and SERT do not specifically underlie psychosocial deficits in stage Huntington's Disease, while higher BDNF storage in delayed mild symptoms PMID: 30039833
  38. These results indicate that genetic variant Met66 decreased the serum BDNF levels in combination with self-reported risk-taking propensity among heroin users. PMID: 30134233
  39. This study demonstrated significant differences in the blood levels of BDNF between people with epilepsy and healthy subjects. PMID: 30140987
  40. Mn-SOD V allele carries a worse outcome profile after stroke, relating to nitrosative stress, inflammatory, and apoptotic response and associated with a BDNF reduction. PMID: 30150066
++ 10 more research findings link this target to additional biology. Showing the 40 most recent — the full set appears on the complete datasheet.
Involvement in disease
Bulimia nervosa 2 (BULN2); Congenital central hypoventilation syndrome (CCHS)
Tissue Specificity
Detected in blood plasma and in saliva (at protein level). Brain. Highly expressed in hippocampus, amygdala, cerebral cortex and cerebellum. Also expressed in heart, lung, skeletal muscle, testis, prostate and placenta.
Subcellular Location
Secreted.; [BDNF precursor form]: Secreted.
Protein Families
NGF-beta family
Database Links

HGNC: 1033

OMIM: 113505

KEGG: hsa:627

STRING: 9606.ENSP00000414303

UniGene: Hs.502182

Precision

Typical Data

Linearity

Recovery

Satisfaction
Quality Rating
Value Rating
Style Rating
X